ArticleCancer biotherapy & radiopharmaceuticals2023

Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry.

Ian R Marsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.